![Dag Nesse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dag Nesse
Director Técnico/Científico/I+D en
ABLIVA AB
.
Perfil
Dag Nesse is currently the Vice President-Clinical Operations at Abliva AB. Previously, he held positions as the Director-Clinical Operations at EpiEndo Pharmaceuticals ehf, the Head-Clinical Operations at Modus Therapeutics AB, and the Head-Clinical Operations at Calliditas Therapeutics AB. Mr. Nesse completed his undergraduate studies at the University of Oslo and BI Norwegian Business School.
Cargos activos de Dag Nesse
| Empresas | Cargo | Inicio |
|---|---|---|
| ABLIVA AB | Director Técnico/Científico/I+D | 01/02/2023 |
Antiguos cargos conocidos de Dag Nesse.
| Empresas | Cargo | Fin |
|---|---|---|
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Director Técnico/Científico/I+D | - |
| CALLIDITAS THERAPEUTICS AB | Director Técnico/Científico/I+D | - |
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for chronic inflammatory diseases | Director Técnico/Científico/I+D | - |
Formación de Dag Nesse.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BI Norwegian Business School
 BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for chronic inflammatory diseases | Health Technology |
- Bolsa de valores
- Insiders
- Dag Nesse
